Hep C's Needle-Free Revolution, FTC Merger Lifeline, Dog Cancer Monoclonals: January 2014 Biotech Shifts
Doctors and patients alike expected more interferon torture for Hep C. AbbVie shattered that with all-oral pills curing 96% of tough cases. Plus, FTC blocks price hikes, and dogs get human-like cancer drugs.